We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
 

RELATED ARTICLES

Molecular Structure of Coronavirus Protein Marks "Critical" Step Towards Vaccine

News

In a new study published in the journal Science , researchers outline their work that could be considered a major step towards the development of a viable vaccine for the 2019 novel coronavirus. The work was deemed so pertinent that the journal Science expedited its review process for the study manuscript.

READ MORE

Mushroom Antioxidant May Relieve Features of "Pregnancy Hypertension"

News

A new study in rats suggests that the natural antioxidant L-ergothioneine could alleviate the characteristics of pre-eclampsia. Researchers at DTU Biosustain work to produce L-ergothioneine biologically.

READ MORE

Insufficient Evidence To Support Herbal Medicines for Weight Loss

News

Researchers from the University of Sydney have conducted the first global review of herbal medicines for weight loss in 19 years, finding insufficient evidence to recommend any current treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE